Temporal changes in immune cell composition and cytokines in response to chemoradiation in rectal cancer

Prospective validation of a lymphocyte infiltration prognostic test in stage III colon cancer patients treated with adjuvant FOLFOX

(2017) Jean-François Emile et al.   EUROPEAN JOURNAL OF CANCER

The immune contexture in cancer prognosis and treatment

(2017) Wolf H. Fridman et al.   Nature Reviews Clinical Oncology

Tumour-infiltrating regulatory T cell density before neoadjuvant chemoradiotherapy for rectal cancer does not predict treatment response

(2017) Melanie J. McCoy et al.   Oncotarget

The clinical use of the platelet/lymphocyte ratio and lymphocyte/monocyte ratio as prognostic predictors in colorectal cancer: a meta-analysis

(2017) Ya-Huan Guo et al.   Oncotarget

Barriers to Radiation-Induced In Situ Tumor Vaccination

(2017) Erik Wennerberg et al.   Frontiers in Immunology

Impact of (chemo)radiotherapy on immune cell composition and function in cervical cancer patients

(2017) H. van Meir et al.   OncoImmunology

TGF-β Signaling in Gastrointestinal Cancers: Progress in Basic and Clinical Research

(2017) Takehiko Yokobori et al.   Journal of Clinical Medicine

Neutrophil to Lymphocyte Ratio (NLR) and Derived Neutrophil to Lymphocyte Ratio (d-NLR) Predict Non-Responders and Postoperative Complications in Patients Undergoing Radical Surgery After Neo-Adjuvant Radio-Chemotherapy for Rectal Adenocarcinoma

(2016) Damiano Caputo et al.   CANCER INVESTIGATION

Tumor-Derived CCL2 Mediates Resistance to Radiotherapy in Pancreatic Ductal Adenocarcinoma

(2016) Anusha Kalbasi et al.   CLINICAL CANCER RESEARCH

Tumor-infiltrating lymphocytes, forkhead box P3, programmed death ligand-1, and cytotoxic T lymphocyte–associated antigen-4 expressions before and after neoadjuvant chemoradiation in rectal cancer

(2015) Feifei Teng et al.   Translational Research

New insights into IL-12-mediated tumor suppression

(2014) S Tugues et al.   CELL DEATH AND DIFFERENTIATION

Prognostic and Predictive Values of the Immunoscore in Patients with Rectal Cancer

(2014) M.-G. Anitei et al.   CLINICAL CANCER RESEARCH

Radiation-Induced IFN-  Production within the Tumor Microenvironment Influences Antitumor Immunity

(2014) A. A. Lugade et al.   JOURNAL OF IMMUNOLOGY

Upregulation of stromal cell-derived factor 1α expression is associated with the resistance to neoadjuvant chemoradiotherapy of locally advanced rectal cancer: Angiogenic markers of neoadjuvant chemoradiation

(2014) HAN JO KIM et al.   ONCOLOGY REPORTS

Baseline neutrophil-lymphocyte ratio (≥2.8) as a prognostic factor for patients with locally advanced rectal cancer undergoing neoadjuvant chemoradiation

(2014) Lijun Shen et al.   Radiation Oncology

Blood biomarkers are helpful in the prediction of response to chemoradiation in rectal cancer: A prospective, hypothesis driven study on patients with locally advanced rectal cancer

(2014) Jeroen Buijsen et al.   RADIOTHERAPY AND ONCOLOGY

Clinical and dosimetric predictors of acute hematologic toxicity in rectal cancer patients undergoing chemoradiotherapy

(2014) T. Jonathan Yang et al.   RADIOTHERAPY AND ONCOLOGY

Serum CCL2 and CCL3 as potential biomarkers for the diagnosis of oral squamous cell carcinoma

(2014) Liang Ding et al.   TUMOR BIOLOGY

Neutrophil-lymphocyte ratio predicts pathologic tumor response and survival after preoperative chemoradiation for rectal cancer

(2014) Ik Yong Kim et al.   BMC Surgery

Systemic inflammatory response is a predictor of outcome in patients undergoing preoperative chemoradiation for locally advanced rectal cancer

(2012) R. Carruthers et al.   Colorectal Disease

Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer

(2012) Suzanne L. Topalian et al.   NEW ENGLAND JOURNAL OF MEDICINE

Circulating lymphocyte number has a positive association with tumor response in neoadjuvant chemoradiotherapy for advanced rectal cancer

(2010) Joji Kitayama et al.   Radiation Oncology